1. Home
  2. DSY vs IGC Comparison

DSY vs IGC Comparison

Compare DSY & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

HOLD

Current Price

$0.35

Market Cap

39.9M

Sector

N/A

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.32

Market Cap

33.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSY
IGC
Founded
2020
2005
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
33.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DSY
IGC
Price
$0.35
$0.32
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.13
AVG Volume (30 Days)
124.0K
435.0K
Earning Date
01-01-0001
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
120.37
N/A
EPS
0.01
N/A
Revenue
$7,323,356.00
$1,106,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
N/A
$15.12
P/E Ratio
$28.97
N/A
Revenue Growth
16.37
N/A
52 Week Low
$0.32
$0.25
52 Week High
$7.33
$0.50

Technical Indicators

Market Signals
Indicator
DSY
IGC
Relative Strength Index (RSI) 19.08 46.96
Support Level $0.32 $0.28
Resistance Level $0.43 $0.36
Average True Range (ATR) 0.02 0.02
MACD 0.00 0.00
Stochastic Oscillator 21.87 58.97

Price Performance

Historical Comparison
DSY
IGC

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: